Literature DB >> 20412387

Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression.

Sarah B Matousek1, Amy M Hein, Solomon S Shaftel, John A Olschowka, Stephanos Kyrkanides, M Kerry O'Banion.   

Abstract

Interleukin (IL)-1beta is a proinflammatory cytokine implicated in several neurodegenerative disorders. Downstream actions of IL-1beta include production of prostaglandin (PG) E(2) by increasing expression of cyclooxygenase (COX) enzymes and prostaglandin E synthase (PGES) isoforms. We recently developed a transgenic mouse carrying a dormant human IL-1beta eXcisional Activation Transgene (XAT) for conditional and chronic up-regulation of IL-1beta in selected brain regions. This model is characterized by regionally specific glial activation, immune cell recruitment, and induction of cytokines and chemokines. Here, we aimed to elucidate the effects of long-term IL-1beta expression on the PGE(2) synthetic pathway and to determine the effects of PGs on inflammation and memory in our model. As expected, PGE(2) levels were significantly elevated after IL-1beta up-regulation. Quantitative real-time PCR analysis indicated significant induction of mRNAs for COX-1 and membranous PGES-1, but not COX-2 or other PGES isoforms. Immunohistochemistry revealed elevation of COX-1 but no change in COX-2 following sustained IL-1beta production. Furthermore, pharmacological inhibition of COX-1 and use of COX-1 knockout mice abrogated IL-1beta-mediated PGE(2) increases. Although COX-1 deficient mice did not present a dramatically altered neuroinflammatory phenotype, they did exhibit improved contextual fear memory. This data suggests a unique role for COX-1 in mediating chronic neuroinflammatory effects through PGE(2) production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412387      PMCID: PMC2897946          DOI: 10.1111/j.1471-4159.2010.06759.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  53 in total

1.  Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia.

Authors:  J M Schwab; T D Nguyen; E Postler; R Meyermann; H J Schluesener
Journal:  Acta Neuropathol       Date:  2000-06       Impact factor: 17.088

2.  Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease.

Authors:  A V Yermakova; M K O'Banion
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

3.  Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats.

Authors:  Ibolja Cernak; Christine O'Connor; Robert Vink
Journal:  Exp Brain Res       Date:  2002-10-02       Impact factor: 1.972

4.  The effects of a novel NSAID on chronic neuroinflammation are age dependent.

Authors:  B Hauss-Wegrzyniak; P Vraniak; G L Wenk
Journal:  Neurobiol Aging       Date:  1999 May-Jun       Impact factor: 4.673

5.  Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury.

Authors:  Jan M Schwab; Rudi Beschorner; Richard Meyermann; Fatma Gözalan; Hermann J Schluesener
Journal:  J Neurosurg       Date:  2002-05       Impact factor: 5.115

6.  Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

Authors:  A V Yermakova; J Rollins; L M Callahan; J Rogers; M K O'Banion
Journal:  J Neuropathol Exp Neurol       Date:  1999-11       Impact factor: 3.685

7.  Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury.

Authors:  Stephanos Kyrkanides; Amy H Moore; John A Olschowka; JoAnna C Daeschner; Jacqueline P Williams; John T Hansen; M Kerry O'Banion
Journal:  Brain Res Mol Brain Res       Date:  2002-08-15

8.  Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Dalia Alvarez; Said Al-Dalain; Gregorio Martínez; Olga Sonia León; Joe E Springer
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

9.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Authors:  Paul S Aisen; Kimberly A Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

10.  Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction.

Authors:  Sylvain Doré; Takashi Otsuka; Toshiaki Mito; Nubuo Sugo; Tracey Hand; Liejun Wu; Patricia D Hurn; Richard J Traystman; Katrin Andreasson
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

View more
  28 in total

Review 1.  Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications.

Authors:  Saba Aïd; Francesca Bosetti
Journal:  Biochimie       Date:  2010-09-22       Impact factor: 4.079

2.  Behavioral, structural and molecular changes following long-term hippocampal IL-1β overexpression in transgenic mice.

Authors:  Amy M Hein; Troy J Zarcone; David B Parfitt; Sarah B Matousek; Dena M Carbonari; John A Olschowka; M Kerry O'Banion
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-12       Impact factor: 4.147

Review 3.  Stress responses: the contribution of prostaglandin E(2) and its receptors.

Authors:  Tomoyuki Furuyashiki; Shuh Narumiya
Journal:  Nat Rev Endocrinol       Date:  2010-11-30       Impact factor: 43.330

4.  Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation.

Authors:  Isabella Russo; Panomwat Amornphimoltham; Roberto Weigert; Sergio Barlati; Francesca Bosetti
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

5.  Interleukin-1β protects astrocytes against oxidant-induced injury via an NF-κB-dependent upregulation of glutathione synthesis.

Authors:  Yan He; Nicole A Jackman; Trista L Thorn; Valarie E Vought; Sandra J Hewett
Journal:  Glia       Date:  2015-04-16       Impact factor: 7.452

Review 6.  Systemic inflammation and delirium: important co-factors in the progression of dementia.

Authors:  Colm Cunningham
Journal:  Biochem Soc Trans       Date:  2011-08       Impact factor: 5.407

7.  Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.

Authors:  Éadaoin W Griffin; Donal T Skelly; Carol L Murray; Colm Cunningham
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

8.  A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.

Authors:  Meredith Hay; Robin Polt; Michael L Heien; Todd W Vanderah; Tally M Largent-Milnes; Kathleen Rodgers; Torsten Falk; Mitchell J Bartlett; Kristian P Doyle; John P Konhilas
Journal:  J Pharmacol Exp Ther       Date:  2019-02-01       Impact factor: 4.030

9.  Deletion or activation of the aryl hydrocarbon receptor alters adult hippocampal neurogenesis and contextual fear memory.

Authors:  Sarah E Latchney; Amy M Hein; M Kerry O'Banion; Emanuel DiCicco-Bloom; Lisa A Opanashuk
Journal:  J Neurochem       Date:  2013-01-07       Impact factor: 5.372

10.  Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.

Authors:  Sang-Ho Choi; Saba Aid; Luca Caracciolo; S Sakura Minami; Takako Niikura; Yasuji Matsuoka; R Scott Turner; Mark P Mattson; Francesca Bosetti
Journal:  J Neurochem       Date:  2012-11-21       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.